Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

23.02 -0.46 (-1.96%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
49 50 Next >
News headline image
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Be Careful In This Unforgiving Market. The Tide Is Turning. ↗
Via Talk Markets
Topics Stocks / Equities
News headline image
Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups' ↗
Ritholtz Wealth Management’s Josh Brown created a new index that tracks the most popular stocks in some of the hottest themes of the market. 
Via Benzinga
News headline image
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health Unusual Options Activity ↗
 
Via Benzinga
News headline image
Where Hims & Hers Health Stands With Analysts ↗
 
Via Benzinga
News headline image
Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS). ↗
Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing? 
Via Chartmill
News headline image
4 Stocks That Crushed Analyst Estimates by More Than Double
Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential. 
Via MarketBeat
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Amazon’s Healthcare Gamble: A New Era of Medical Disruption
Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
Unpacking the Latest Options Trading Trends in Hims & Hers Health ↗
 
Via Benzinga
News headline image
Price Over Earnings Overview: Hims & Hers Health ↗
 
Via Benzinga
News headline image
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate. 
Via MarketBeat
Topics Government Lawsuit
News headline image
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market ↗
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
News headline image
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well. 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines. 
Via MarketBeat
Topics Government
News headline image
Why Hims & Hers Stock Jumped on Massive FDA News ↗
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model. 
Via The Motley Fool
News headline image
Technical Monday: A Fresh Look At The “Vanity” Trade ↗
Nu Skin is an American multi-level marketing company for personal care products and dietary supplements. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
What's Going On With Hims & Hers Health Stock Monday? ↗
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans to nominate Marty Makary to lead the Food and Drug Administration (FDA).... 
Via Benzinga
Topics Government
News headline image
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio? ↗
The top performers in the last week were Lemonade, Inc., Archer Aviation Inc., C3.ai, Inc., Oklo Inc., Applied Digital Corporation, Unity Software Inc., Nebius Group N.V., NuScale Power Corporation,... 
Via Benzinga
News headline image
Hims & Hers New Growth Category Is a Huge Surprise ↗
Is the food business the right business for Hims & Hers to be in? 
Via The Motley Fool
News headline image
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
News headline image
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? ↗
Via The Motley Fool
News headline image
Guardant Health Stock Sees RS Rating Jump To 83 ↗
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. 
Via Investor's Business Daily
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.